Skip to main content

Site navigation

  • University of Technology Sydney home
  • Home

    Home
  • For students

  • For industry

  • Research

Explore

  • Courses
  • Events
  • News
  • Stories
  • People

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt
  • Study at UTS

    • arrow_right_alt Find a course
    • arrow_right_alt Course areas
    • arrow_right_alt Undergraduate students
    • arrow_right_alt Postgraduate students
    • arrow_right_alt Research Masters and PhD
    • arrow_right_alt Online study and short courses
  • Student information

    • arrow_right_alt Current students
    • arrow_right_alt New UTS students
    • arrow_right_alt Graduates (Alumni)
    • arrow_right_alt High school students
    • arrow_right_alt Indigenous students
    • arrow_right_alt International students
  • Admissions

    • arrow_right_alt How to apply
    • arrow_right_alt Entry pathways
    • arrow_right_alt Eligibility
arrow_right_altVisit our hub for students

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Apply for a coursearrow_right_alt
  • Current studentsarrow_right_alt
  • Scholarshipsarrow_right_alt
  • Featured industries

    • arrow_right_alt Agriculture and food
    • arrow_right_alt Defence and space
    • arrow_right_alt Energy and transport
    • arrow_right_alt Government and policy
    • arrow_right_alt Health and medical
    • arrow_right_alt Corporate training
  • Explore

    • arrow_right_alt Tech Central
    • arrow_right_alt Case studies
    • arrow_right_alt Research
arrow_right_altVisit our hub for industry

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Find a UTS expertarrow_right_alt
  • Partner with usarrow_right_alt
  • Explore

    • arrow_right_alt Explore our research
    • arrow_right_alt Research centres and institutes
    • arrow_right_alt Graduate research
    • arrow_right_alt Research partnerships
arrow_right_altVisit our hub for research

For you

  • Libraryarrow_right_alt
  • Staffarrow_right_alt
  • Alumniarrow_right_alt
  • Current studentsarrow_right_alt

POPULAR LINKS

  • Find a UTS expertarrow_right_alt
  • Research centres and institutesarrow_right_alt
  • University of Technology Sydney home
Explore the University of Technology Sydney
Category Filters:
University of Technology Sydney home University of Technology Sydney home
  1. home
  2. arrow_forward_ios ... Newsroom
  3. arrow_forward_ios ... 2024
  4. arrow_forward_ios 02
  5. arrow_forward_ios Vaccine research ranges into pastures new

Vaccine research ranges into pastures new

2 February 2024

Having reshaped our lives during the pandemic, mRNA vaccine technologies are set to change the face of agriculture.

Photo of Professor Garry Myers

Professor Garry Myers. Photo Andy Roberts

With more than 50 million doses of messenger ribonucleic acid (mRNA) vaccines having been given to Australians to stop the spread of COVID-19, most of us associate the emerging technology with human health.

But Professor Garry Myers, Director of the UTS Australian Institute for Microbiology and Infection (AIMI), thinks we’re just beginning to tap the potential of the technology platform.

“The capabilities that are offered by mRNA technology have been validated by the whole COVID-19 pandemic. There’s so much potential, particularly for use with animals,” Professor Myers says.

“We’re looking to leverage off the work that we’re doing here currently with mRNA vaccines to look into various aspects that are relevant to agriculture and biosecurity.”

He will spend six months in 2024 exploring these fields as the Fulbright Distinguished Chair in Agriculture and Life Sciences at Kansas State University.

The research at AIMI into mRNA vaccines began with a focus on new therapeutics to beat anti-microbial resistance, a growing problem in hospitals as well as agriculture.

An mRNA approach allows us to think about rapid, personalised vaccines. 

"It would be possible to take a swab of whatever’s infecting an individual and isn't responding to antibiotics, and quickly make a vaccine for them that's either prophylactic or therapeutic,” he says.

From these beginnings, their research has broadened to explore a variety of agricultural uses such as immunisation against crippling animal diseases such as cattle ticks and sheep foot rot.

While finding new ways to beat these diseases could save hundreds of millions of dollars each year, Professor Myers sees the potential of a new class of animal vaccines to reshape the livestock industries.

“We’re also looking at vaccines for treating multiple diseases with one injection. While well-established for humans, such as with the Measles-Mumps-Rubella vaccine we get as kids, this hasn't really been done for animals yet,” he says.

“If we look at tailored, multivalent vaccines, we can potentially target the animal diseases in a particular region. The pathogens that say a cow is exposed to in northern Queensland is different to those in Victoria.”

In an industry where disease (such as those from cattle ticks) is one of the main obstacles preventing livestock surviving in certain regions, these regional vaccines could enable breeds that current live only in southern Australia to range further north.

“There’s a lot of work happening globally using this new paradigm, but animal health is slower. The agricultural sector is firmly focused on the bottom line and mRNA technology will get cheaper all the time,” he says.

Professor Myers will be able to progress this research in new ways through the Fulbright Distinguished Chair.

“Kansas State University is one of the key hubs for biosecurity research in the US, partnering with the US Government huge tornado-proof biosecurity facility that goes straight down underground and enables the most sensitive research into animal diseases,” he says.

“I’ll be able to bring the research and learnings from the Fulbright back to UTS and help us to continue to take a leading role in developing mRNA technologies for Australia.”

Share
Share this on Facebook Share this on Twitter Share this on LinkedIn
Back to Health and science

Related News

  • Petri dish. Adobe Stock
    How to slow the spread of deadly ‘superbugs’
  • A doctor examines a lung xray in a hologram setting surrounded by images of data.
    AI assist for COVID-19 diagnosis

Acknowledgement of Country

UTS acknowledges the Gadigal People of the Eora Nation and the Boorooberongal People of the Dharug Nation upon whose ancestral lands our campuses now stand. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands. 

University of Technology Sydney

City Campus

15 Broadway, Ultimo, NSW 2007

Get in touch with UTS

Follow us

  • Instagram
  • LinkedIn
  • YouTube
  • Facebook

A member of

  • Australian Technology Network
Use arrow keys to navigate within each column of links. Press Tab to move between columns.

Study

  • Find a course
  • Undergraduate
  • Postgraduate
  • How to apply
  • Scholarships and prizes
  • International students
  • Campus maps
  • Accommodation

Engage

  • Find an expert
  • Industry
  • News
  • Events
  • Experience UTS
  • Research
  • Stories
  • Alumni

About

  • Who we are
  • Faculties
  • Learning and teaching
  • Sustainability
  • Initiatives
  • Equity, diversity and inclusion
  • Campus and locations
  • Awards and rankings
  • UTS governance

Staff and students

  • Current students
  • Help and support
  • Library
  • Policies
  • StaffConnect
  • Working at UTS
  • UTS Handbook
  • Contact us
  • Copyright © 2025
  • ABN: 77 257 686 961
  • CRICOS provider number: 00099F
  • TEQSA provider number: PRV12060
  • TEQSA category: Australian University
  • Privacy
  • Copyright
  • Disclaimer
  • Accessibility